SCHEMBL810505

SCHEMBL810505

OSc1ccc(Br)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19099432 0.92 ALDH1A1 (0.48)
SCHEMBL3411276 0.73 MAOA (0.64)
SCHEMBL4123832 0.73 MAOA (0.64)
SCHEMBL224947 0.73 CYP2A6 (0.57)
SCHEMBL6363151 0.71
Water SCHEMBL28293836 0.71 CYP2A6 (0.53)
SCHEMBL18508 0.71
SCHEMBL23657328 0.70 MAPT (0.38)
SCHEMBL381447 0.69 ALDH1A1 (0.58)
SCHEMBL7938361 0.69 NR1H2 (0.74)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108601788-A EIF 4A-inhibiting compounds and methods relating thereto 效应治疗股份有限公司 2018-09-28 CN disclosed
EP-2345652-A1 Antiviral compounds Abbott Laboratories (US) 2011-07-20 EP disclosed
US-7915411-B2 Anti-viral compounds ABBOTT LABORATORIES (US) 2011-03-29 US disclosed
US-7872134-B2 2-{[2-(substituted amino)ethyl]sulfonyl}ethyl N,N-bis(2-chloroethyl)phosphorodiamidates TELIK, INC. (US) 2011-01-18 US disclosed
US-7655799-B2 2{[2-(substituted amino)ethyl]sulfonyl}ethyl N,N,N',N'-tetrakis(2-chloroethyl)phosphorodiamidates TELIK, INC. (US) 2010-02-02 US disclosed
EP-2097139-A1 2-{[2-(SUBSTITUTED AMINO)ETHYL]SULFONYL}ETHYL N,N,N',N'-TETRAKIS(2 -CHLOROETHYL)PHOSPHORODIAMIDATES TELIK, INC. (US) 2009-09-09 EP disclosed
WO-2009076473-A1 2-{[2-(SUBSTITUTED AMINO)ETHYL]SULFONYL}ETHYL N,N-BIS(2- CHLOROETHYL)PHOSPHORODIAMIDATES TELIK, INC. (US) 2009-06-18 WO disclosed
US-20090156559-A1 2-ethyl N,N-bis(2-chloroethyl)phosphorodiamidates TELIK, INC. 2009-06-18 US disclosed
EP-1971611-A1 ANTI-VIRAL COMPOUNDS Abbott Laboratories (US) 2008-09-24 EP disclosed
WO-2008066515-A1 2-({2-OXO-2-[(PYRIDIN-3-YLMETHYL)AMINO]ETHYL}SULFONYL)ETHYL N,N,N',N'-TETRAKIS(2-CHLOROETHYL)PHOSPHORODIAMIDATE TELIK, INC. (US) 2008-06-05 WO disclosed
WO-2008066526-A1 2-{[2-(SUBSTITUTED AMINO)ETHYL]SULFONYL}ETHYL N,N,N',N'-TETRAKIS(2 -CHLOROETHYL)PHOSPHORODIAMIDATES TELIK, INC. (US) 2008-06-05 WO disclosed
US-20080125398-A1 2-ETHYL N,N,N',N'-tetrakis(2-chloroethyl)phosphorodiamidates TELIK, INC. 2008-05-29 US disclosed
US-20080125397-A1 2 (SULFONYL)ETHYL N,N,N',N' tetrakis(2 chloroethyl)phosphorodia TELIK, INC. 2008-05-29 US disclosed
US-20070197558-A1 ANTI-VIRAL COMPOUNDS ABBVIE INC. 2007-08-23 US disclosed
WO-2007081517-A2 ANTI-VIRAL COMPOUNDS ABBOTT LABORATORIES (US) 2007-07-19 WO disclosed